TRIUMEQ cpr disp 5mg/60mg/30mg bte 90 pce
7680689200019
CH-68920
J05AR13
08.03.0.
1 / 3
google
Details
- Product number
- 6892001
- CPT
- -
- Packaging group
- 90
- Unit
- Tablette(n)
- Composition
- dolutegravirum 5 mg ut dolutegravirum natricum, abacavirum 60 mg ut abacaviri sulfas, lamivudinum 30 mg, mannitolum, cellulosum microcristallinum, povidonum K 29-32, carboxymethylamylum natricum A, cellulosum microcristallinum silicificatum, crospovidonum, acesulfamum kalicum, sucralosum, natrii stearylis fumaras, aromatica Erdbeercrèmearoma, Überzug: talcum, macrogolum 4000, poly(alcohol vinylicus), E 171, E 172 (flavum), pro compresso obducto corresp. natrium 0.9 mg.
Articles (1)
Triumeq, Tabletten zur Herstellung einer Suspension zum Einnehmen
Tabletten zur Herstellung einer Suspension zum Einnehmen
90
Official Swissmedic V2 data
Additional information from the official database
Official medical documents
Detailed composition
| Substance | Quantity | Type | Category |
|---|---|---|---|
|
(N/A)
|
5.0 MG | Substance | Wirkstoff (Principe actif) |
|
(N/A)
|
- | Substance | WIZUS |
|
(N/A)
|
60.0 MG | Substance | Wirkstoff (Principe actif) |
|
(N/A)
|
- | Substance | WIZUS |
|
(N/A)
|
30.0 MG | Substance | Wirkstoff (Principe actif) |
|
(N/A)
|
- | Substance | HNIDK |
|
(N/A)
|
- | Substance | HNIDK |
|
(N/A)
|
- | Substance | HNIDK |
|
(N/A)
|
- | Substance | HNIDK |
|
(N/A)
|
- | Substance | HNIDK |
|
(N/A)
|
- | Substance | HNIDK |
|
(N/A)
|
- | Substance | HNIDK |
|
(N/A)
|
- | Substance | HNIDK |
|
(N/A)
|
- | Substance | HNIDK |
|
(N/A)
|
- | Substance | AROMA |
|
(N/A)
|
- | Substance | HNIDK |
|
(N/A)
|
- | Substance | HNIDK |
|
(N/A)
|
- | Substance | HNIDK |
|
(N/A)
|
- | Substance | FNIDK |
|
(N/A)
|
- | Substance | FTODK |
|
(N/A)
|
0.9 MG | Substance | HBESI |
Authorization holder
ViiV Healthcare GmbH
6340 Baar
Authorization information
- Swissmedic authorization number
- 68920
- Drug name
- Triumeq, Tabletten zur Herstellung einer Suspension zum Einnehmen
- Galenic form
- TAB
- ATC Code
- J05AR13
- Authorization status
- Z
- Dispensation category
- A
- First authorization
- 24/08/2023
- Authorization expiration date
- 23/08/2028
- IT number
- 08.03.0.
- Domain
- Human medicine
Packaging details
- Description (FR)
- TRIUMEQ cpr disp 5mg/60mg/30mg bte 90 pce
- Description (DE)
- TRIUMEQ Disp Tabl 5mg/60mg/30mg Ds 90 Stk
- Market launch
- 24/08/2023
- Narcotic (BTM)
- No